Navigation Links
Elucidation of the genome for diabetics with DNA chips

The genome of patients with type 2 diabetes (DT2) has been elucidated, for the first time, thanks to the use of new DNA chip technologies allowing 400,000 DNA mutations to be studied simultaneously. New genes conferring a predisposition to DT2 have been identified. They include the zinc transporter of pancreatic insulin-secreting cells (ZnT8), which is a potential target for treatment. This study of the French population was carried out as a French-British-Canadian collaboration between the teams directed by Philippe Froguel (CNRS, University of Lille 2, Pasteur Institute, Imperial College London) and Rob Sladek (McGill University, Montreal, Canada). About 70% of the genetic risk of DT2 is accounted for by these new discoveries, published online in Nature on February 11 2007. This work opens up entirely new avenues of prevention and treatment for this disease.

There are more than 200 million diabetics worldwide, and it has been predicted that this number will double by 2030. This increase in the number of diabetics is linked to the obesity epidemic, which currently affects 1.1 thousand million people, including 150 million children. However, heredity also makes a major contribution to the development of DT2. Abnormalities in insulin secretion appear very early in the children of diabetic parents. These individuals become hyperglycaemic when they put on weight and are resistant to the insulin they produce. The team of Philippe Froguel was the first to identify a gene associated with DT2 ?that encoding glucokinase ?in 1992. Several other such genes have since been discovered, but together these genes account for only a small proportion of DT2 cases. Insufficient knowledge of the human genome and the absence of cheap, simple-to-use, rapid analytical techniques hampered progress in medical research for many years. The recent sequencing of the human genome and the establishment of a complete map of DNA variations in the human species have finally made it possible
'"/>

Source:CNRS


Page: 1 2 3

Related biology news :

1. Man and mouse share genome structures
2. Whole genome fine map of rice completed
3. Study finds more than one-third of human genome regulated by RNA
4. A bacterial genome reveals new targets to combat infectious disease
5. Scientists decipher genome of fungus that can cause life-threatening infections
6. Highly adaptable genome in gut bacterium key to intestinal health
7. Fleshing out the genome
8. Agilent Technologies new genome analysis technology set to accelerate Australia fight against mesothelioma
9. wFleaBase: the Daphnia genome database
10. NHGRI targets 12 more organisms for genome sequencing
11. Chimp genome reveals a retroviral invasion

Post Your Comments:
(Date:12/3/2009)...ds the world when it comes to investment in energy...and Physical Sciences Research Council (EPSRC) Chi...ed: "Scientific and engineering research has alrea...ower solutions, but more investment is needed to d...we are to meet our carbon emission targets by 2020...
(Date:12/2/2009)...PHIA Children exposed to secondhand cigarette smo...r in adulthood, even if they never smoked. , Re...miology, Biomarkers & Prevention , a journal of th...t of a special tobacco focus in the December issue...s will be diagnosed with lung cancer; more than 15...
(Date:12/2/2009)...PHIA Cigarette smoking and alcohol consumption be...cts the patient,s future risk of death, according ...show a similar effect among those who continued th...r survivors are counseled to quit smoking; despite...continued to smoke even after their cancer diagnos...
Breaking Biology News(10 mins):Research is vital to a cleaner, greener, low carbon future 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Syngenta Issues EUR 500 Million Eurobond 12745 1Syngenta Issues EUR 500 Million Eurobond 12745 2Physician Receives Bachelors Degree After 50 Years 49750 1Physician Receives Bachelors Degree After 50 Years 49750 2Helix Biopharma Corp Begins Trading on the OTCQX International Market Listing as HXBPF 49749 1Helix Biopharma Corp Begins Trading on the OTCQX International Market Listing as HXBPF 49749 2Helix Biopharma Corp Begins Trading on the OTCQX International Market Listing as HXBPF 49749 3Helix Biopharma Corp Begins Trading on the OTCQX International Market Listing as HXBPF 49749 4
...ls Network, an initiative designed to address the ...tegration of imaging biomarkers into multi-center ... a supporter. , SNM, the world,s largest medical ...ssionals, inaugurated the Clinical Trials Network ...g development through the integration and standard...
...al of a tissue sample is now the standard for diag... are accurate but only offer a snapshot of the tum...or for weeks or months after the biopsy, tracking ... be much more valuable, says Michael Cima, MIT pro...as developed the first implantable device that can...
...erican Society of Civil Engineers (ASCE) has prese...ng, Stabile Professor for Innovation and Technolog... as an expert, contact Sheryl Weinstein at 973-596...f civil and environmental engineering, has 35 year...ivil engineering in both the academic field and pr...
Other Biology News:SNM's clinical trials network gains added support from industry leader 2MIT’s implantable device offers continuous cancer monitoring 2Civil engineers name NJIT's John Schuring Educator of Year Award 2
(Date:12/2/2009)... Dec. 2 Peregrine Pharma...mpletion of patient enrollment in a dose confirmat...s with relapsed glioblastoma multiforme (GBM), the...eted monoclonal antibody linked to a radioisotope ...BM. Cotara specifically targets cells at the cent...
(Date:12/2/2009)...EM, Israel, December 2 Gamida Cell...e preclinical (animal study) safety and,efficacy o... from Weill,Cornell Medical College and Gamida Cel...ed anemias such as Cooley,s Anemia. , Gam... expand, ex vivo,populations of stem/progenitor c...
(Date:12/2/2009)...ec. 2 /PRNewswire-Asia/ -- The world is going thro...d uncertainty is part of many,businesses and indus...een,relatively immune to the economic downturn, be...During the midst of the difficult times this year,...augurated an R&D center in Shanghai, the large...
(Date:12/1/2009)...c. 1 Reportlinker.com announces th...s catalogue: ,, Chromium - Global Market Tren...hromium---Global-Market-Trends.html ,, Worldwi...stainless steel, while growth in aerospace and ind...growth of chromium metal. Environmental constraint...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9
...., Oct. 5 Bionovo, Inc.,(Nasdaq: BNVI ), a leade...ective drugs in the areas of women,s health and ca... CFO of Bionovo, Inc., will present at the 4th,Ann...e place on October 11, 2007 at 12:30 p.m. PDT,at t...o web cast and slide presentation of the event wil...
...CO, Calif., Oct. 5 Cerimon,Pharmaceuticals, Inc.,...and,Chief Executive Officer, will present at the 2...07, at 9:30 a.m. PDT at the Palace Hotel in San,Fr...acific Heights room. About Cerimon Pharmaceutical...tical company dedicated,to developing and commerci...
...5 The Coalition for a,Competitive Pharmaceutical ... on the Food and Drug Administration,s announcemen...Efficiency" (GIVE): "With consumers, employers, i...nage escalating prescription drug costs, it is cri...ays to enhance timely generic access.,Today,s anno...
Other Biology Technology:CCPM Issues Statement on FDA's GIVE Initiative 2
...ified Formulation: 50mM Tris-HCl, pH 7.5, 0.1mM EG...1% 2-mercaptoethanol and 50% glycerol. Properites:...d enzyme Purification: DEAE-Sephadex, ammonium sul..., Superdex 200, and Mono Q chromatography to >95%....
Beacon 2000 One-Step FP Std from Invitrogen
Beacon 2000 Chamber (6mm, Minimum Vol - 100 uL) from Invitrogen
EvoQuest Custom Peptide Services from Invitrogen
Biology Products: